Is xgeva denosumab monoclonal antibody

Yes, Xgeva (denosumab) is a monoclonal antibody. It works by inhibiting RANKL (receptor activator of nuclear factor kappa-Β ligand), which is involved in the formation, function, and survival of osteoclasts, the cells responsible for bone resorption. Xgeva is primarily used to prevent skeletal-related events in patients with bone metastases from solid tumors.